Electrode and electrode configuration for base catheter
By designing an electrode body with a roughly triangular shape, the problem of electrode misalignment on adjacent ridges was solved, enabling more electrode attachments and higher mapping and ablation accuracy.
Patent Information
- Application Number
- CN202410593755.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-04-18
- Filing Date
- 2024-05-14
- Publication Date
- 2024-11-22
AI Technical Summary
The electrode design of existing medical probes is offset and aligned on adjacent ridges, resulting in less electrode attachment and affecting the accuracy of mapping and ablation.
An electrode body is designed including a first end and a second end. The first end forms a generally triangular shape and has a larger area than the second end. The electrodes converge along the longitudinal axis and are attached to the ridge of an expandable basket assembly, so that the electrodes can be closely aligned and contact the tissue when the assembly is expanded.
This increases the number of electrodes attached to the probe, improving the accuracy of mapping and ablation, while allowing the electrodes to be tightly assembled within the sheath.
Smart Images

Figure CN118986359A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to and the benefit of U.S. Provisional Patent Application No. 63 / 502,543 (Agent Docket No.: BIO6847USPSP1-253757.000369), filed on May 16, 2023, under 35 U.S.C. §119(e), the entire contents of which are incorporated herein by reference. Technical Field
[0003] The present invention relates generally to medical devices, and in particular to medical probes having electrodes, and further, but not exclusively, to medical probes suitable for mapping and ablation of cardiac tissue. Background Art
[0004] Arrhythmias, such as atrial fibrillation (AF), occur when an area of cardiac tissue abnormally conducts electrical signals to adjacent tissue. This disrupts the normal cardiac cycle and causes an irregular heartbeat. Certain procedures are used to treat arrhythmias, including surgically disrupting the source of the signal causing the arrhythmia and disrupting the conduction pathways for such signals. By selectively ablating cardiac tissue through the application of energy via a catheter, it is sometimes possible to stop or alter the propagation of unwanted electrical signals from one part of the heart to another.
[0005] Areas of cardiac tissue may be mapped by a medical probe to identify abnormal electrical signals. The same or different medical probes may be used for ablation. Some exemplary probes include a plurality of ridges on which electrodes are disposed. The electrodes are typically attached to the ridges, and the ridges are configured to bend radially outward when deployed from a sheath. The electrodes are then brought into contact with the tissue to map or ablate the tissue. The electrodes must typically be arranged on the ridges in such a way that the electrodes on adjacent ridges are offset from one another. This is due to the limited space within the sheath, and if the electrodes on adjacent ridges are aligned with one another, the electrodes cannot be assembled together within the sheath. However, the offset alignment of the electrodes results in fewer electrodes being attached to the ridges, which reduces the accuracy of mapping and ablation. Therefore, there is a need in the art for an electrode design that enables electrodes to be aligned on adjacent ridges and allows a greater number of electrodes to be attached to the ridges while still being able to fit within the sheath. These and other problems may be addressed by the technology disclosed herein. Summary of the invention
[0006] According to the disclosed technology, an electrode is provided, the electrode comprising a body including a first end and a second end. The body may extend from the first end to the second end along a longitudinal axis. The body may be configured for attachment to a spine of an expandable basket assembly such that the first end is oriented for contacting tissue when the expandable basket assembly is in an expanded configuration. The first end may include a conductive surface forming a generally triangular shape, and the area of the first end is greater than the area of the second end. The body may converge along the longitudinal axis from the first end to the second end.
[0007] The medical probe includes a tubular shaft including a proximal end and a distal end, the tubular shaft extending along a longitudinal axis, and an expandable basket assembly coupled to the distal end of the tubular shaft. The expandable basket assembly includes: a plurality of ridges configured to bend radially outward from the longitudinal axis when the expandable basket assembly is in an expanded configuration; and a plurality of electrodes attached to the plurality of ridges, each of the plurality of electrodes including a body including a first end and a second end, the body being attached to a corresponding ridge of the plurality of ridges such that the first end is oriented for contacting tissue when the expandable basket assembly is in the expanded configuration. The first end may include a conductive surface forming a generally triangular shape, and the area of the first end is greater than the area of the second end, and the body may converge from the first end to the second end.
[0008] The disclosed technology may include a medical probe including a tubular shaft including a proximal end and a distal end. The tubular shaft may extend along a longitudinal axis. The medical probe may further include an expandable basket assembly coupled to the distal end of the tubular shaft. The expandable basket assembly may include a plurality of ridges configured to bend radially outward from the longitudinal axis when the expandable basket assembly is in an expanded configuration. The expandable basket assembly may include a plurality of electrodes attached to the plurality of ridges.
[0009] Each electrode of the plurality of electrodes may include a body including a tetrahedral shape. The tetrahedral shape may include an outwardly facing end and an inwardly facing end. The outwardly facing end may include a conductive surface having an area greater than an area of the inwardly facing end and configured to contact tissue when the expandable basket assembly is in an expanded configuration. The body may converge from the outwardly facing end to the inwardly facing end. BRIEF DESCRIPTION OF THE DRAWINGS
[0010] The present invention will be more fully understood through the following detailed description of the embodiments of the present disclosure in conjunction with the accompanying drawings, in which:
[0011] Figure 1 is a schematic illustration of a medical system including a medical probe having a distal end including electrodes according to the disclosed technology;
[0012] Figure 2is a schematic illustration of a basket catheter including electrodes according to the disclosed technology;
[0013] Figure 3A is a perspective view of an electrode according to the disclosed technology;
[0014] Figure 3B is a front view of an electrode according to the disclosed technology;
[0015] Figure 3C According to the disclosed technology Figure 3B A cross-sectional view of the electrode taken along line AA;
[0016] Figure 3D is a top view of an electrode according to the disclosed technology;
[0017] Figure 3E According to the disclosed technology Figure 3D A cross-sectional view of the electrode taken along line BB;
[0018] Figure 4A is a schematic illustration of a medical probe according to the disclosed technology;
[0019] Figure 4B is a schematic illustration of a medical probe in a sheath according to the disclosed technology;
[0020] Figure 5 is a perspective view of a plurality of ridges and electrodes of a medical probe according to the disclosed technology;
[0021] Fig. 6A is a side view of an electrode grouping according to the disclosed technology;
[0022] Figure 6B is a top view of an electrode grouping according to the disclosed technology;
[0023] Figure 6C is a top view of another electrode grouping according to another example of the disclosed technology; and
[0024] Figure 7 According to the disclosed technology, the ridges and electrodes are Figure 6B A cross-sectional view taken along line CC. DETAILED DESCRIPTION
[0025] The following specific embodiments should be read in conjunction with the accompanying drawings, wherein the same elements are labeled the same in different drawings. The accompanying drawings (not necessarily drawn to scale) depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates the principles of the invention by way of example and not by way of limitation. This description will clearly enable those skilled in the art to prepare and use the invention, and describes several embodiments, adaptations, variations, alternatives, and uses of the invention, including the best modes currently believed to be implemented in the invention.
[0026] As used herein, the term "about" or "approximately" for any numerical value or range indicates a suitable dimensional tolerance that allows a part or assembly of components to achieve its intended purpose as described herein. More specifically, "about" or "approximately" may refer to a range of ±20% of the value of the recited value, for example, "about 90%" may refer to a range of values from 71% to 110%.
[0027] In addition, as used herein, the terms "patient", "recipient", "user" and "subject" refer to any human or animal subject, and are not intended to limit the systems or methods to human use, but the use of the subject invention in human patients represents a preferred embodiment. Likewise, the term "proximal" refers to a position closer to an operator or physician, while "distal" refers to a position farther from an operator or physician.
[0028] As discussed herein, the vasculature of a "patient," "recipient," "user," and "subject" can be that of a human or any animal. It should be understood that the animal can be of any suitable type, including, but not limited to, a mammal, a veterinary animal, a livestock animal, or a pet animal, etc. For example, the animal can be a laboratory animal (e.g., a rat, dog, pig, monkey, etc.) that is specifically selected to have certain characteristics similar to those of a human. It should be understood that the subject can be, for example, any suitable human patient.
[0029] As discussed herein, a "physician" may include a physician, surgeon, technician, scientist, operator, or any other individual or delivery instrumentation associated with delivering a multi-electrode catheter for treating drug-refractory atrial fibrillation to a subject.
[0030] As discussed herein, when referring to the devices and corresponding systems of the present disclosure, the term "ablation" refers to components and structural features configured to reduce or prevent the generation of unstable cardiac signals in cells by utilizing non-thermal energy (such as irreversible electroporation (IRE)), which are interchangeably referred to as pulsed electric fields (PEF) and pulsed field ablation (PFA) in the present disclosure. "Ablation" as used throughout the present disclosure, when referring to the devices and corresponding systems of the present disclosure, refers to non-thermal ablation of cardiac tissue for certain conditions, including but not limited to arrhythmias, atrial flutter ablation, pulmonary vein isolation, supraventricular tachycardia ablation, and ventricular tachycardia ablation. The term "ablation" also includes known methods, devices, and systems for achieving various forms of body tissue ablation as understood by those skilled in the relevant art.
[0031] As discussed herein, the terms "bipolar" and "monopolar" when used to refer to ablation protocols describe ablation protocols that differ in current paths and electric field distribution. "Bipolar" refers to an ablation protocol that utilizes a current path between two electrodes as described below, both electrodes being positioned at a treatment site; the current density and electric flux density at each of the two electrodes are generally approximately equal. "Monopolar" refers to an ablation protocol that utilizes a current path between two electrodes as described below, wherein one electrode having a high current density and a high electric flux density is positioned at the treatment site, and a second electrode having a relatively lower current density and a lower electric flux density is positioned away from the treatment site.
[0032] As discussed herein, the terms "biphasic pulse" and "monophasic pulse" refer to corresponding electrical signals. "Biphasic pulse" refers to an electrical signal having a positive voltage phase pulse (referred to herein as "positive phase") and a negative voltage phase pulse (referred to herein as "negative phase"). "Monophasic pulse" refers to an electrical signal having only a positive phase or only a negative phase. Preferably, the system providing the biphasic pulse is configured to prevent the application of a direct current voltage (DC) to the patient. For example, the average voltage of the biphasic pulse may be zero volts relative to ground or other common reference voltage. Additionally or alternatively, the system may include a capacitor or other protective component. The voltage amplitude of the biphasic and / or monophasic pulses is described herein, and it should be understood that the voltage amplitude expressed is the absolute value of the approximate peak amplitude of each of the positive voltage phase and / or the negative voltage phase. Each phase of the biphasic pulse and the monophasic pulse preferably has a square shape, which has a substantially constant voltage amplitude during most of the phase duration. The phases of the biphasic pulse are separated in time by an interphase delay. The interphase delay duration is preferably less than or approximately equal to the duration of the phase of the biphasic pulse. The interphase delay duration is more preferably about 25% of the duration of a phase of the biphasic pulse.
[0033] As discussed herein, the terms "tubular" and "tube" should be interpreted broadly and are not limited to structures that are perfect cylinders or have a completely circular cross-section or a uniform cross-section throughout their length. For example, tubular structures are often shown as structures that are substantially perfect cylinders. However, tubular structures may have tapered or curved outer surfaces without departing from the scope of the present disclosure.
[0034] The present disclosure relates to systems, methods or uses and devices that can be used to perform IRE ablation of cardiac tissue to treat arrhythmias. Ablation energy is typically provided to cardiac tissue by a distal portion of a catheter that can deliver ablation energy along the tissue to be ablated. Some exemplary catheters include a three-dimensional structure at the distal portion and are configured to apply ablation energy from various electrodes positioned on the three-dimensional structure. Fluoroscopy can be used to visualize ablation procedures incorporating such exemplary catheters.
[0035] Ablation of cardiac tissue to correct a malfunctioning heart using the application of thermal techniques such as radiofrequency (RF) energy and cryoablation is a well-known procedure. Typically, in order to successfully ablate using thermal techniques, it is necessary to measure cardiac electrode potentials at various locations of the myocardium. In addition, temperature measurements during ablation provide data that can achieve ablation efficacy. Typically, for ablation procedures using thermal ablation, electrode potentials and temperatures are measured before, during, and after the actual ablation. RF methods may have the risk of causing tissue charring, burns, steam bursts, phrenic nerve paralysis, pulmonary vein stenosis, and esophageal fistulas. Cryoablation is an alternative to RF ablation that can reduce some of the thermal risks associated with RF ablation. However, manipulating a cryoablation device and selectively applying cryoablation is generally more challenging than RF ablation; therefore, cryoablation is not feasible in certain anatomical geometries that can be reached by electrical ablation devices.
[0036] The present disclosure may include electrodes configured for RF ablation, cryoablation, and / or irreversible electroporation (IRE). Throughout the present disclosure, IRE may be referred to interchangeably as pulsed electric field (PEF) ablation and pulsed field ablation (PFA). IRE as discussed in the present disclosure is a non-thermal cell death technique that can be used for ablation of atrial arrhythmias. In order to ablate using IRE / PEF, biphasic voltage pulses are applied to destroy the cellular structure of the myocardium. Biphasic pulses are non-sinusoidal and can be tuned to target cells based on the electrophysiology of the cells. In contrast, in order to ablate using RF, a sinusoidal voltage waveform is applied to generate heat at the treatment area, heating all cells in the treatment area indiscriminately. Therefore, IRE has the ability to avoid adjacent heat-sensitive structures or tissues, which will have benefits in reducing possible complications known to be affected by ablation or separation modalities. In addition or alternatively, monophasic pulses can be used.
[0037] Electroporation can be induced by applying a pulsed electric field across biological cells to cause holes to be reversibly (temporarily) or irreversibly (permanently) produced in the cell membrane. When a pulsed electric field is applied, the cell has a transmembrane electrostatic potential that is elevated above the static potential. When the transmembrane electrostatic potential remains below the threshold potential, electroporation is reversible, which means that the hole can be closed when the applied pulsed electric field is removed, and the cell can self-repair and survive. If the transmembrane electrostatic potential is elevated above the threshold potential, electroporation is irreversible and the cell becomes permanently permeable. Therefore, the cell dies due to the loss of homeostasis and usually dies by apoptosis. Typically, different types of cells have different threshold potentials. For example, cardiac cells have a threshold potential of approximately 500V / cm, while for bones, the threshold potential is 3000V / cm. These differences in threshold potentials allow IRE to selectively target tissues based on the threshold potential.
[0038] The solution of the present disclosure includes a system and method for applying an electrical signal from a catheter electrode positioned near myocardial tissue to generate ablation energy to ablate myocardial tissue. In some examples, the system and method can effectively ablate the targeted tissue by inducing irreversible electroporation. In some examples, the system and method can effectively induce reversible electroporation as part of a diagnostic procedure. Reversible electroporation occurs when the electricity applied by the electrode is lower than the electric field threshold of the target tissue that allows cell repair. Reversible electroporation does not kill cells, but allows physicians to view the effects of reversible electroporation on electrical activation signals near the target location. Exemplary systems and methods for reversible electroporation are disclosed in U.S. Patent Publication 2021 / 0162210, the entire contents of which are incorporated herein by reference and attached to the appendix of this document.
[0039] The effectiveness of pulsed electric field and its induction of reversible electroporation and / or irreversible electroporation may be affected by the physical parameters of the system and the biphasic pulse parameters of the electrical signal. The physical parameters may include electrode contact area, electrode spacing, electrode geometry, etc. The examples proposed herein generally include physical parameters suitable for effectively inducing reversible electroporation and / or irreversible electroporation. The biphasic pulse parameters of the electrical signal may include voltage amplitude, pulse duration, pulse phase delay, pulse delay, total application time, energy delivered, etc. In some examples, the parameters of the electrical signal may be adjusted to induce both reversible and irreversible electroporation given the same physical parameters. Examples of various ablation systems and methods including IRE are provided in U.S. Patent Publications 2021 / 0169550A1, 2021 / 0169567A1, 2021 / 0169568A1, 2021 / 0161592A1, 2021 / 0196372A1, 2021 / 0177503A1, and 2021 / 0186604A1, the entire contents of each of which are incorporated herein by reference and are attached as an appendix to this document.
[0040] refer to Figure 1 , which shows an exemplary catheter-based electrophysiological mapping and ablation system 10. The system 10 includes a plurality of catheters that are inserted into a chamber or vascular structure of a heart 12 by a physician 24 through the vascular system of a patient 23 via the skin. Typically, a delivery sheath catheter is inserted into the left atrium or right atrium near a desired location in the heart 12. Then, a plurality of catheters may be inserted into the delivery sheath catheter to reach the desired location. The plurality of catheters may include a catheter dedicated to sensing intracardiac electrogram (IEGM) signals, a catheter dedicated to ablation, and / or a catheter dedicated to both sensing and ablation. An exemplary catheter 14 configured for sensing and ablation is illustrated herein. The physician 24 brings the distal end 28 of the catheter 14 (also sometimes referred to herein as a basket catheter 28 or an expandable basket assembly) into contact with the heart wall for sensing a target site in the heart 12. For ablation, the physician 24 would similarly bring the distal end of the ablation catheter to the target site for ablation.
[0041] The catheter 14 is an exemplary catheter that includes one (preferably multiple) electrodes 26, optionally distributed on a plurality of spines 22 at a distal tip 28 and configured to sense IEGM signals. The catheter 14 may additionally include a position sensor 29 embedded in or near the distal tip 28 for tracking the position and orientation of the distal tip 28. Optionally and preferably, the position sensor 29 is a magnetically based position sensor that includes three magnetic coils for sensing three-dimensional (3D) position and orientation.
[0042] The magnetic-based position sensor 29 can operate with the positioning pad 25, which includes a plurality of magnetic coils 32 configured to generate a magnetic field in a predetermined working space. The real-time position of the distal tip 28 of the catheter 14 can be tracked based on the magnetic field generated by the positioning pad 25 and sensed by the magnetic-based position sensor 29. The details of the magnetic-based position sensing technology are described in U.S. Patents 5,391,199, 5,443,489, 5,558,091, 6,172,499, 6,239,724, 6,332,089, 6,484,118, 6,618,612, 6,690,963, 6,788,967, 6,892,091, the entire contents of each of which are incorporated herein by reference and attached to the appendix of this document.
[0043] The system 10 includes one or more electrode patches 38 positioned in contact with the skin of the patient 23 to establish a position reference for impedance-based tracking of the positioning pad 25 and the electrodes 26. For impedance-based tracking, current is directed toward the electrodes 26 and sensed at the electrode skin patches 38 so that the position of each electrode can be triangulated via the electrode patches 38. Details of impedance-based position tracking techniques are described in U.S. Patent Nos. 7,536,218, 7,756,576, 7,848,787, 7,869,865, and 8,456,182, each of which is incorporated herein by reference in its entirety and is attached as an appendix to this document.
[0044] Recorder 11 displays electrograms 21 captured using surface ECG electrodes 18 and intracardiac electrograms (IEGMs) captured using electrodes 26 of catheter 14. Recorder 11 may include pacing capabilities for pacing the cardiac rhythm and / or may be electrically connected to a separate pacemaker.
[0045] The system 10 may include an ablation energy generator 50 adapted to conduct ablation energy to one or more electrodes at the distal end of a catheter configured for ablation. The energy generated by the ablation energy generator 50 may include, but is not limited to, radio frequency (RF) energy or pulsed field ablation (PFA) energy (including monopolar or bipolar high voltage DC pulses that may be used to achieve irreversible electroporation (IRE)), or a combination thereof.
[0046] The patient interface unit (PIU) 30 is an interface configured to establish electrical communication between catheters, electrophysiology equipment, a power source, and a workstation 55 for controlling the operation of the system 10. The electrophysiology equipment of the system 10 may include, for example, multiple catheters, a positioning pad 25, surface ECG electrodes 18, electrode patches 38, an ablation energy generator 50, and a recorder 11. Optionally and preferably, the PIU 30 additionally includes processing capabilities for enabling real-time calculation of the position of the catheter and for performing ECG calculations.
[0047] The workstation 55 includes a memory, a processor unit with a memory or storage device loaded with appropriate operating software, and a user interface capability. The workstation 55 can provide multiple functions, optionally including: (1) three-dimensional (3D) modeling of the endocardial anatomy and rendering the model or anatomical map 20 for display on the display device 27; (2) displaying on the display device 27 an activation sequence (or other data) compiled from the recorded electrograms 21 as representative visual markers or images superimposed on the rendered anatomical map 20; (3) displaying the real-time position and orientation of multiple catheters within the heart chamber; and (4) displaying on the display device 27 a site of interest (such as where ablation energy has been applied). A commercial product embodying elements of the system 10 may be CARTO TM 3System was purchased from Biosense Webster, Inc., 31 Technology Drive, Suite 200, Irvine, CA 92618, USA.
[0048] Figure 2 is a diagram showing a method of performing a closure operation according to the disclosed technology, such as by being pushed out of the sheath 80 ( Figure 4B Schematic illustration of a perspective view of a basket catheter 28 with electrodes 26 in an expanded form (shown in FIG. Figure 2 As shown, the basket catheter 28 may include a plurality of ridges 22 that, when in an expanded form, may bend radially outward from the longitudinal axis 86. The ridges 22 may be formed of a biocompatible elastic material, such as Nitinol, such that the ridges 22 are naturally biased to expand outward to the expanded form.
[0049] Each ridge 22 may include one or more electrodes 26 attached thereto. As will be described in more detail herein, the electrodes 26 may be configured such that the electrodes 26 may be arranged on the ridges 22 in an aligned manner on adjacent ridges 22, such as Figure 2 Thus, the basket catheter 28 of the disclosed technology can be configured to include a greater number of electrodes 26 than previous catheter designs. The electrodes 26 can be configured so that the electrodes can be folded together in a compact configuration, such as FIG. 4A to FIG. 7 The electrodes 26 described herein may be configured for mapping and / or ablation of tissue.
[0050] Figure 3Ais a perspective view of an electrode 26 according to the disclosed technology. As shown, the electrodes 26 may each have a generally tetrahedral shape. In this manner, the electrodes 26 may be attached to the spine 22 so that the outward-facing surface 302 of the electrode 26 (also referred to herein as the "first end" and the "first face") may have a larger surface area than the inward-facing end 328 of the electrode 26 (also referred to herein as the "second end" or the "fourth corner"). Because the electrodes 26 are generally tetrahedral in shape, the electrodes may be configured to fold together in a tight configuration, like orange segments, when attached to the spine 22 and arranged on the basket catheter 28. Therefore, the electrodes 26 enable the basket catheter 28 to include a greater number of electrodes 26 while still being able to be folded and fitted within the sheath 80.
[0051] All or some of the electrodes 26 may include conductive materials. For example, all of the electrodes 26 may be made entirely of gold, silver, platinum, palladium, stainless steel (and their respective alloys). Alternatively, only a portion of the electrodes 26 (e.g., the first face 302) may be made of the materials just listed. These materials also have high thermal conductivity, which allows minimal heat generated on the tissue (i.e., by the ablation energy delivered to the tissue) to be conducted through the electrodes to the back of the electrodes (i.e., the portion of the electrodes on the inner side of the ridges), and then to the blood pool in the heart 12. The electrodes may be configured to deliver electrical pulses having a peak voltage of at least 900 volts (V).
[0052] The outwardly facing surface 302 can be configured to contact tissue, and thus by having a larger surface area than the inwardly facing end 328, the outwardly facing surface 302 can be better configured for detecting electrophysiological signals and / or for providing ablative energy to tissue. In addition, the electrode 26 can have a plurality of faces that form a generally tetrahedral shape. For example, the electrode 26 can have at least a first face 302 (the outwardly facing side), a second face 304, a third face 306, and a fourth face 308 (the side facing inwardly facing the electrode 26). Figure 3A 310, a second edge 312, a third edge 314, a fourth edge 316, a fifth edge 318, and a sixth edge 320 (in Figure 3A Each of the first edge 310, the second edge 312, the third edge 314, the fourth edge 316, the fifth edge 318, and the sixth edge 320 may be rounded to prevent damage to tissue and other components of the medical probe (e.g., the sheath 80). The plurality of edges may converge at a plurality of corners. The plurality of corners may include a first corner 322, a second corner 324, a third corner 326, and a fourth corner 328 (also referred to herein as a "second end" or "inwardly facing end"). Figure 3AEach of the faces, edges, and corners just described and shown in FIG. 3B to FIG. 3E Similar faces, edges and corners as shown in .
[0053] Now go to FIG. 3B to FIG. 3E , according to the disclosed technology, Figure 3B is a front view of the electrode 26, Figure 3C yes Figure 3B A cross-sectional view of an electrode, Figure 3D is a top view of the electrode, and Figure 3E yes Figure 3D Cross-sectional view of the electrode. FIG. 3B to FIG. 3E The views shown illustrate various features of the electrode 26, including general angles and proportions of the example electrodes. FIG. 3B to FIG. 3E The views of the electrodes shown and described are provided for illustrative purposes and should not be construed as limiting. Other electrodes 26 having different shapes, angles, proportions, etc. may similarly be construed as falling within the scope of the present disclosure.
[0054] like Figure 3B As shown, the electrode 26 may have a first face 302 (outwardly facing side) configured to contact tissue. The first face 302 may be generally formed in the shape of a triangle. In this non-limiting example, the first face 302 is shown to form an isosceles triangle, wherein the second edge 312 and the third edge 314 have a first length L1 that is different from the length L2 of the first edge 310. Because the first face 302 forms an isosceles triangle, the first angle θ1 between the second edge 312 and the third edge 314 may be different from the second angle θ2 between the first edge 310 and the second edge 312, which is equal to the angle θ2 between the first edge 310 and the third edge 312. However, as will be understood, various angles and lengths of the face may be configured according to various other examples. For example, the first face 302 may form an acute triangle, an obtuse triangle, an equilateral triangle, an unequal triangle, a right triangle, etc. In addition, although the electrode 26 is shown as having a first face 302 (and other faces 304, 306, 308) forming a triangle, it will be understood that one or more faces of the triangle may form a shape other than a triangle. Thus, various other arrangements of the disclosed technology may be configured such that the outwardly facing sides have a larger surface area than the inwardly facing sides, so that the electrodes 26 can be folded together to form a compact grouping of electrodes 26 that can fit within the sheath 80.
[0055] Figure 3C The electrode 26 is along Figure 3B The cross-sectional view is taken along the line AA of FIG. The line AA extends from the fourth corner 328 (the inwardly facing end) through the middle of the first face 302 to a point 330 disposed in the middle of the first edge 310. Figure 3CAs shown, the electrode 26 may be configured such that the fourth corner 328 (the inward-facing end) may be offset a distance D1 from a center line C1 that extends perpendicularly from a point P1 located at the center of the triangle formed by the first face 302. That is, a center line C1 extending perpendicularly to the first face 302 from a first point P1 at the center of the first face 302 is spaced a distance D1 from a line PL1 that is parallel to the first line and extends through a second point at the center of the fourth corner 328 (the "inward-facing end" or "second end"). In other words, the electrode 26 may form a tetrahedron that is not a regular tetrahedron. In this way, the fourth corner 328 of the electrode 26 may be configured to better fit together when the electrodes 26 are grouped together, such as with respect to Figures 5 to 7 Described in more detail.
[0056] like Figure 3D As shown, the second face 304 of the electrode 26 may form an equilateral triangle. That is, the second edge 312, the fourth edge 316, and the fifth edge 318 may each have the same length L3, and each of the second edge 312, the fourth edge 316, and the fifth edge 318 may form a third angle θ3 that is equal to each other. As described above, Figure 3D The configuration of the second side 304 shown in FIG. 3 is provided for illustrative purposes, and the second side 304 may be configured according to various other arrangements.
[0057] Figure 3E The electrode 26 is along Figure 3D The cross-sectional view is taken along the line BB of FIG. The line BB extends from the fourth corner 328 (the inwardly facing end) through the middle of the second face 304 to a point 340 disposed in the middle of the second edge 312. Similar to FIG. Figure 3C The cross section of the electrode 26 is shown, Figure 3E The cross-sectional view of shows that the second end 328 can be arranged so that it is aligned offset by a distance D2 from a center line C2, which extends perpendicularly from a point P2 at the center of the second face 304. That is, the center line C2 extending perpendicularly to the second face 304 from the second point P2 at the center of the second face 304 is spaced apart by a distance D2 from a line PL2 that is parallel to the center line C2 and extends through a point at the center of the fourth corner 328 (the "inward-facing end" or "second end"). In this way, the fourth corner 328 (the inward-facing end) of the electrode 26 can be configured to better fit together when the electrodes 26 are grouped together, as described with respect to Figures 5 to 7 As will be appreciated, distances D1 and D2 may be varied to affect the configuration of the tetrahedral shape of electrode 26 suitable for a particular application.
[0058] like Figure 4AAs shown, the basket catheter 28 may include a plurality of flexible ridges 22 formed at the end of a tubular shaft 84 and connected to the tubular shaft 84 at the proximal end and to a distal hub 210 at the distal end. During a medical procedure, the physician 34 may move the basket catheter 28 out of the sheath 80 and into an expanded form (e.g., Figure 2 As shown), the basket catheter 28 is deployed. Figure 4A and Figure 4B As shown, because electrodes 26 are configured according to the shapes shown and described herein, electrodes 26 can be configured to be folded together and formed into a compact group for delivery from and retrieval into a sheath.
[0059] The spine 22 may have an elliptical (e.g., circular) cross-section or a rectangular (may appear flat) cross-section and include a flexible, resilient material (e.g., a shape memory alloy such as nickel titanium, also known as Nitinol, or other materials such as cobalt chromium, stainless steel, titanium, or even a polymer material) forming a strut, as will be described in more detail herein. The disclosed technology may be applicable to a basket catheter 28 formed of a single spine 22 or a plurality of spines 22, wherein each spine 22 is attached at two ends (as just described).
[0060] The ridges 22 may be formed from a single sheet of planar material. In some examples, the ridges 22 may be formed from a single sheet of planar material such that the ridges 22 converge toward a central intersection. In other examples, the ridges 22 may be formed separately and then attached at both ends, as shown and just described.
[0061] As will be appreciated, the ridge 22 may be electrically isolated from the electrode 26 to prevent arcing from the electrode 26 to the ridge 22. For example, an insulating sheath (not shown) may be provided between the ridge 22 and the electrode 26, but one skilled in the art will appreciate that other insulating coverings are also contemplated. For example, an insulating coating may be applied to the ridge 22, the electrode 26, or both. The insulating sheath may be made of a biocompatible, electrically insulating material such as a polyamide-polyether (Pebax) copolymer, polyethylene terephthalate (PET), polyurethane, polyimide, polyparaxylene, silicone, and the like. In some examples, the insulating material may include biocompatible polymers, including but not limited to: polyetheretherketone (PEEK), polyglycolic acid (PGA), poly(lactic-co-glycolic acid) (PLGA), polycaprolactone (PCL), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), poly-L-lactide, polydioxane, polycarbonate, and polyanhydride, wherein the proportions of certain polymers are selected to control the extent of the inflammatory response. The insulating sheath may also include one or more additives or fillers, such as polytetrafluoroethylene (PTFE), boron nitride, silicon nitride, silicon carbide, aluminum oxide, aluminum nitride, zinc oxide, and the like.
[0062] Figure 5 2 shows a perspective view of an electrode 26 in a folded form attached to a ridge 22. As shown, the electrode 26 can be attached to the ridge 22 such that a majority of the electrode 26 is disposed on the outwardly facing side of the ridge post 22. Fig. 6A and Figure 6B As better shown in FIG. 1 , the electrodes 26 may be arranged in an alternating first orientation 26A and a second orientation 26B. The second orientation 26B may be flipped 180 degrees from the first orientation 26A so that the electrodes 26 can better fit together when in a folded form (e.g., FIG. 4A to FIG. 7 In addition, Figure 6B As can be seen in FIG. 1 , the first face 302 can be arranged in an outwardly facing orientation, while the fourth corner 328 (second end) is arranged in an inwardly facing orientation. Figure 6B In the example shown, the fourth corners 328 can converge and define a lumen 610 that extends through the grouping of electrodes 26. For example, the lumen 610 can be used to ensure that enough space is reserved for the electrodes 26 to align together if there is some variation in alignment. Additionally, in some examples, if, for example, it is desired that irrigation fluid flow through the probe even when the basket catheter 28 is retracted into the sheath 80, the lumen 610 can be configured to allow irrigation fluid to flow therethrough.
[0063] Figure 6CAnother example arrangement of the electrode 26 in a folded configuration is shown. In this example, the electrode 26 includes a rounded first face 602, which can help prevent the electrode 26 from damaging tissue or other components of the medical probe (e.g., the interior of the sheath, a hemostatic valve, etc.). That is, the rounded first face 602 can include a compound curved surface that presents a rounded profile relative to the longitudinal axis 86. As shown, the rounded first face 602 can be outwardly facing and configured to contact tissue. In addition, the rounded first face 602 can make it easier to retract the basket catheter 28 into the sheath 80.
[0064] Figure 7 The ridge 22 and the electrode 26 are along Figure 6B A cross-sectional view taken along line CC. Figure 7 As shown and as previously mentioned Figure 3C As described, the electrodes 26 may be configured such that the fourth corner 328 (the inwardly facing end) may be offset by a distance D1 from the centerline C1, which extends perpendicularly from a point P1 located at the center of the triangle formed by the first face 302. Thus, the second end 328 of each electrode 26 may converge toward a point in the middle of the electrode 26 grouping, which is offset from the center of the first face 302. In addition, as shown, the first edge 310 may be oriented generally perpendicularly relative to the ridge post 22. However, as will be appreciated, the electrodes 26 may be configured such that the electrodes 26 can be folded together in a compact manner, thereby allowing various other configurations of the electrodes 26 to be attached to adjacent ridges 22 while still being able to fit compactly within the sheath 80.
[0065] The disclosed technology described herein can be further understood according to the following terms:
[0066] Item 1: An electrode for a medical probe, the electrode comprising: a body, the body comprising a first end and a second end, the body extending along a longitudinal axis from the first end to the second end, the body being configured for attachment to a ridge of an expandable basket assembly such that the first end is oriented for contacting tissue when the expandable basket assembly is in an expanded configuration, the first end comprising a conductive surface forming a generally triangular shape, and an area of the first end is greater than an area of the second end, and the body converges along the longitudinal axis from the first end to the second end.
[0067] Clause 2: The electrode of clause 1, the generally triangular shape of the first end comprising an acute triangle.
[0068] Clause 3: The electrode of clause 2, the generally triangular shape of the first end comprising an isosceles triangle.
[0069] Clause 4: The electrode of clause 2, the generally triangular shape of the first end comprising an equilateral triangle.
[0070] Clause 5: An electrode as recited in any preceding clause, wherein the body comprises a tetrahedron.
[0071] Item 6: An electrode according to Item 5, wherein the second end is not aligned with the first end such that a first line extending perpendicular to the conductive surface from a first point at the center of the first end is separated by a distance from a second line parallel to the first line and extending through a second point at the center of the second end.
[0072] Clause 7: The electrode of any preceding clause, the body configured for attachment to the ridge such that a first edge of the generally triangular shape is oriented perpendicular to the ridge.
[0073] Clause 8: An electrode as recited in any preceding clause, the body comprising rounded edges.
[0074] Clause 9: The electrode of any preceding clause, wherein the body comprises a material selected from the group consisting of: gold, palladium, silver, platinum, stainless steel, and combinations thereof.
[0075] Clause 10: An electrode as recited in any preceding clause, configured for ablation of the tissue.
[0076] Clause 11: The electrode of any preceding clause, the conductive surface forming the generally triangular shape comprising a compound curved surface exhibiting a rounded profile relative to the longitudinal axis.
[0077] Clause 12: An electrode as recited in any preceding clause, configured for mapping electrophysiological properties of the tissue.
[0078] Item 13: A medical probe comprising: a tubular shaft including a proximal end and a distal end, the tubular shaft extending along a longitudinal axis; an expandable basket assembly connected to the distal end of the tubular shaft, the expandable basket assembly comprising: a plurality of ridges configured to bend radially outward from the longitudinal axis when the expandable basket assembly is in an expanded configuration; and a plurality of electrodes attached to the plurality of ridges, each of the plurality of electrodes comprising: a body including a first end and a second end, the body being attached to a corresponding ridge of the plurality of ridges such that the first end is oriented for contacting tissue when the expandable basket assembly is in the expanded configuration, the first end comprising a conductive surface forming a generally triangular shape, and an area of the first end is greater than an area of the second end, and the body converges from the first end to the second end.
[0079] Clause 14: The medical probe of clause 13, wherein the generally triangular shape of the first end comprises an acute triangle.
[0080] Clause 15: The medical probe of clause 14, wherein the generally triangular shape of the first end comprises an isosceles triangle.
[0081] Clause 16: The medical probe of clause 14, wherein the generally triangular shape of the first end comprises an equilateral triangle.
[0082] Clause 17: The medical probe of any one of clauses 13 to 16, wherein the body comprises a tetrahedron.
[0083] Clause 18: A medical probe according to clause 17, wherein the second end is not aligned with the first end such that a first line extending perpendicular to the conductive surface from a first point at the center of the first end is separated by a distance from a second line parallel to the first line and extending through a second point at the center of the second end.
[0084] Clause 19: The medical probe of any of clauses 13 to 18, wherein the plurality of electrodes are attached to each of the ridges such that each adjacent ridge includes an electrode, and wherein the plurality of electrodes are aligned in a direction perpendicular to the longitudinal axis.
[0085] Clause 20: The medical probe of Clause 19, the body of each electrode of the plurality of electrodes being attached to the respective ridge such that a first edge of the generally triangular shape is oriented perpendicular to the ridge.
[0086] Clause 21: A medical probe according to clause 20, wherein a first electrode of the plurality of electrodes is attached to the corresponding ridge in a first orientation such that a first edge of the conductive surface is located at the distal end of the body, and wherein a second electrode of the plurality of electrodes is attached to an adjacent ridge of the plurality of ridges in a second orientation such that a first edge of the conductive surface is located at the proximal end of the body.
[0087] Clause 22: The medical probe of Clause 21, wherein the plurality of electrodes are attached to the plurality of ridges such that the plurality of electrodes are attached to adjacent ridges in alternating first and second orientations.
[0088] Clause 23: The medical probe of any one of clauses 13 to 22, wherein the body comprises rounded edges.
[0089] Clause 24: The medical probe of any of clauses 13 to 23, wherein the body comprises a material selected from the group consisting of: gold, palladium, silver, platinum, stainless steel, and combinations thereof.
[0090] Clause 25: The medical probe of any one of clauses 13 to 24, wherein the plurality of electrodes are configured for ablation of the tissue.
[0091] Clause 26: The medical probe of Clause 25, the plurality of electrodes configured to deliver electrical pulses for irreversible electroporation, the pulses comprising a peak voltage of at least 900 volts (V).
[0092] Clause 27: The medical probe of any one of clauses 13 to 26, wherein the plurality of electrodes are configured for mapping electrophysiological properties of tissue.
[0093] Clause 28: The medical probe of any of clauses 13 to 27, wherein each ridge of the plurality of ridges comprises a material selected from the group consisting of: nitinol, cobalt chromium, stainless steel, titanium, and combinations thereof.
[0094] Clause 29: The medical probe of any one of clauses 13 to 28, wherein the ridge comprises a polymer material.
[0095] Item 30: A medical probe comprising: a tubular shaft comprising a proximal end and a distal end, the tubular shaft extending along a longitudinal axis; an expandable basket assembly coupled to the distal end of the tubular shaft, the expandable basket assembly comprising: a plurality of ridges configured to bend radially outward from the longitudinal axis when the expandable basket assembly is in an expanded configuration; and a plurality of electrodes attached to the plurality of ridges, each of the plurality of electrodes comprising a body comprising a tetrahedral shape comprising an outward-facing end and an inward-facing end, the outward-facing end comprising a conductive surface having an area larger than an area of the inward-facing end, and the conductive surface being configured to contact tissue when the expandable basket assembly is in the expanded configuration, the body converging from the outward-facing end to the inward-facing end.
[0096] Clause 31: The medical probe of clause 30, the outwardly facing end comprising a generally triangular shape, the generally triangular shape comprising an acute-angled triangle.
[0097] Clause 32: The medical probe of clause 31, wherein the generally triangular shape comprises an isosceles triangle.
[0098] Clause 33: The medical probe of clause 32, wherein the generally triangular shape comprises an equilateral triangle.
[0099] Clause 34: A medical probe according to any one of clauses 30 to 33, wherein the inwardly facing end is not aligned with the outwardly facing end such that a first line extending perpendicular to the conductive surface from a first point at the center of the first end is separated by a distance from a second line parallel to the first line and extending through a second point at the center of the second end.
[0100] Clause 35: The medical probe of any of clauses 30 to 34, the body configured for attachment to the spine such that the first edge of the generally triangular shape is oriented perpendicular to the spine.
[0101] Clause 36: The medical probe of any of clauses 31 to 35, wherein the plurality of electrodes are attached to each of the ridges such that each adjacent ridge includes an electrode, and wherein the plurality of electrodes are aligned in a direction perpendicular to the longitudinal axis.
[0102] Clause 37: The medical probe of clause 36, the body of each electrode of the plurality of electrodes being attached to the respective ridge such that a first edge of the generally triangular shape is oriented perpendicular to the ridge.
[0103] Clause 38: A medical probe according to clause 37, wherein a first electrode of the plurality of electrodes is attached to the corresponding ridge in a first orientation such that a first edge of the conductive surface is located at the distal end of the body, and wherein a second electrode of the plurality of electrodes is attached to an adjacent ridge of the plurality of ridges in a second orientation such that a first edge of the conductive surface is located at the proximal end of the body.
[0104] Clause 39: The medical probe of clause 38, wherein the plurality of electrodes are attached to the plurality of ridges such that the plurality of electrodes are attached to adjacent ridges in alternating first and second orientations.
[0105] Clause 40: The medical probe of any one of clauses 30 to 39, wherein the body comprises rounded edges.
[0106] Clause 41: The medical probe of any of Clauses 30 to 40, wherein the body comprises a material selected from the group consisting of: gold, palladium, silver, platinum, stainless steel, and combinations thereof.
[0107] Clause 42: The medical probe of any of clauses 30 to 41, wherein the plurality of electrodes are configured for ablation of the tissue.
[0108] Clause 43: The medical probe of Clause 42, the plurality of electrodes configured to deliver electrical pulses for irreversible electroporation, the pulses comprising a peak voltage of at least 900 volts (V).
[0109] Clause 44: The medical probe of any one of clauses 30 to 41, wherein the electrodes are configured to map electrophysiological properties of the tissue.
[0110] The above embodiments are cited by way of example, and the present invention is not limited by what is specifically shown and described above. On the contrary, the scope of the present invention includes combinations and sub-combinations of the various features described above, as well as variations and modifications thereof, which will occur to those skilled in the art upon reading the above description, and which are not disclosed in the prior art.
Claims
1. An electrode for a medical probe, the electrode comprising: a body including a first end and a second end, the body extending along a longitudinal axis from the first end to the second end, the body being configured for attachment to a spine of an expandable basket assembly such that the first end is oriented for contacting tissue when the expandable basket assembly is in an expanded configuration, The first end includes a conductive surface forming a generally triangular shape, and an area of the first end is greater than an area of the second end, and The body converges along the longitudinal axis from the first end to the second end. The electrode according to claim 1 , wherein the body comprises a tetrahedron.
3. An electrode according to claim 2, wherein the second end is not aligned with the first end so that a first line extending perpendicular to the conductive surface from a first point at the center of the first end is separated by a distance from a second line parallel to the first line and extending through a second point at the center of the second end.
4. The electrode of claim 1, the body configured for attachment to the ridge such that a first edge of the generally triangular shape is oriented perpendicular to the ridge.
5. The electrode of claim 1, configured for ablation of the tissue.
6. The electrode of claim 1, the conductive surface forming the generally triangular shape comprising a compound curved surface having a rounded profile relative to the longitudinal axis.
7. The electrode of claim 1, configured to map electrophysiological properties of the tissue.
8. A medical probe, comprising: a tubular shaft comprising a proximal end and a distal end, the tubular shaft extending along a longitudinal axis; and an expandable basket assembly coupled to the distal end of the tubular shaft, the expandable basket assembly comprising: a plurality of ridges configured to curve radially outward from the longitudinal axis when the expandable basket assembly is in an expanded configuration; and a plurality of electrodes attached to the plurality of ridges, each electrode of the plurality of electrodes comprising: a body including a first end and a second end, the body being attached to a corresponding ridge of the plurality of ridges such that the first end is oriented for contacting tissue when the expandable basket assembly is in the expanded configuration, The first end includes a conductive surface forming a generally triangular shape, and an area of the first end is greater than an area of the second end, and The body converges from the first end to the second end.
9. The medical probe of claim 8, wherein the body comprises a tetrahedron.
10. The medical probe according to claim 9, wherein: The second end is not aligned with the first end such that a first line extending perpendicular to the conductive surface from a first point at the center of the first end is spaced a distance from a second line parallel to the first line and extending through a second point at the center of the second end.
11. The medical probe according to claim 8, wherein: The plurality of electrodes are attached to each of the ridges such that each adjacent ridge includes an electrode, and wherein the plurality of electrodes are aligned in a direction perpendicular to the longitudinal axis.
12. The medical probe of claim 11, the body of each electrode of the plurality of electrodes being attached to the respective ridge such that a first edge of the generally triangular shape is oriented perpendicular to the ridge.
13. The medical probe according to claim 12, wherein: A first electrode of the plurality of electrodes is attached to the respective ridge in a first orientation such that the first edge is located at a distal end of the body, and Wherein a second electrode of the plurality of electrodes is attached to an adjacent ridge of the plurality of ridges in a second orientation such that the first edge is located at a proximal end of the body.
14. The medical probe according to claim 13, wherein: The plurality of electrodes are attached to the plurality of ridges such that the plurality of electrodes are attached to adjacent ridges in alternating first and second orientations.
15. A medical probe, comprising: a tubular shaft comprising a proximal end and a distal end, the tubular shaft extending along a longitudinal axis; and an expandable basket assembly coupled to the distal end of the tubular shaft, the expandable basket assembly comprising: a plurality of ridges configured to curve radially outward from the longitudinal axis when the expandable basket assembly is in an expanded configuration; and a plurality of electrodes attached to the plurality of ridges, each of the plurality of electrodes comprising a body comprising a tetrahedral shape including an outwardly facing end and an inwardly facing end, the outwardly facing end comprising a conductive surface having an area greater than an area of the inwardly facing end and configured to contact tissue when the expandable basket assembly is in the expanded configuration, the body converging from the outwardly facing end to the inwardly facing end.
16. The medical probe according to claim 15, wherein: The inwardly facing end is not aligned with the outwardly facing end such that a first line extending perpendicular to the conductive surface from a first point at the center of the first end is spaced a distance from a second line parallel to the first line and extending through a second point at the center of the second end.
17. The medical probe according to claim 15, wherein: The plurality of electrodes are attached to each of the ridges such that each adjacent ridge includes an electrode, and wherein the plurality of electrodes are aligned in a direction perpendicular to the longitudinal axis.
18. The medical probe of claim 17, the body of each electrode of the plurality of electrodes being attached to the respective ridge such that a first edge of the conductive surface is oriented perpendicular to the ridge.
19. The medical probe according to claim 15, wherein: A first electrode of the plurality of electrodes is attached to the respective ridge in a first orientation such that a first edge of the conductive surface is located at a distal end of the body, and Wherein a second electrode of the plurality of electrodes is attached to an adjacent ridge of the plurality of ridges in a second orientation such that a first edge of the conductive surface is located at a proximal end of the body.
20. The medical probe according to claim 19, wherein: The plurality of electrodes are attached to the plurality of ridges such that the plurality of electrodes are attached to adjacent ridges in alternating first and second orientations.
